Havn Life Sciences Stock News

CEO, Tim Moore will share recent partnership and distribution news and a roadmap for the Company's plans for the next quarterVancouver, British Columbia--(Newsfile Corp. - June 6, 2022) - Havn Life Sc

VANCOUVER, BC / ACCESSWIRE / April 30, 2022 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP) , a biotechnology company pursuing standardized extraction of psychedelic compounds for investiga

                              HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research The naturally derived GMP psilocybin will be exported through distribution partner Mycrodose Therapeutics Inc. to the University of Wisconsin-Madison, Contract Research Organization for Revive Therapeutics   Vancouver, BC, February 24, 2022 -- Inves...

The partnership is a integral step in the The Company's path to market in the U.S., achieving one of its most important milestones to-date VANCOUVER, BC / ACCESSWIRE / September 23, 2021 / Havn Life S

VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction o

The partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company"

HAVN Life will export to Delic Labs in Canada for quality control and testing. This makes HAVN Life the first in the Caribbean Community and Common Market to export psilocybin.

Here are seven stocks to buy if you're optimistic about the potential for alternative therapies to become mainstream treatments. The post 7 Stocks to Buy if You Think Alternative Therapies Are the Fut

The Agreement with P.A. Benjamin Manufacturing Company whom operates a GMP compliant facility in Jamaica VANCOUVER, BC / ACCESSWIRE / July 27, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)

The Company will supply naturally-derived psilocybin for the development of psilocybin microdosing health products VANCOUVER, BC / ACCESSWIRE / July 8, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC P

Most companies' success stories come as a result of wanting to accomplish a greater purpose. For HAVN Life Sciences Inc. (CSE: HAVN) (OTC PINK: HAVLF) (FSE: 5NP) CEO Tim Moore, his personal experience

Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP)  (th

HAVN Life works towards substantiating a patent application and preclinical work VANCOUVER, BC / ACCESSWIRE / May 17, 2021 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company

Havn Life will join 80+ other small cap and micro-cap companies at leading event for investors VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP)

Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC